BACKGROUND: The Global Allergy and Asthma European Network (GA2LEN) is a consortium of 26 leading European research centres committed to establish a European research area of excellence in the field of allergy and asthma. AIM: One of the GA2LEN work packages was designed to identify and compare the existing European birth cohort studies on asthma and atopic diseases. The present review compares their subjective and objective outcomes as well as exposure variables. METHODS: A common database was established to assess study characteristics of observational birth cohort studies designed to examine asthma and atopic diseases. Data were collected by visiting most of the participating research teams and interviewing all relevant study personnel. For each study, the type of objective/subjective outcome parameters and potentially influential factors were recorded precisely for every time point during follow-up. RESULTS: Eighteen birth cohort studies on asthma and atopic diseases were identified in eight European countries. Thirteen studies collected data on specific immunoglobulin E (IgE) to various inhalant and food allergens, whereas 12 performed skin prick tests (many at several time points during follow up). Several studies measured lung function, but across the cohorts no comparable standard procedures were used. For subjective evaluation of asthma and allergic rhinitis most studies applied the ISAAC questionnaire (sometimes modified), whereas the assessment of eczema was rather heterogeneous across the studies. CONCLUSION: This GA2LEN initiative established a unique common database of 18 European birth cohorts on asthma and atopic diseases. For selected cohorts, it seems that pooling data and performing common analyses may be possible to examine associations between certain exposure variables (e.g. pet ownership, tobacco smoke exposure and day-care) and selected outcome measures for atopy, asthma or allergic rhinitis (e.g. sensitization assessed by IgE or skin prick tests, doctor's diagnosis of asthma, parental perception regarding asthma/wheezing or hay fever symptoms).
BACKGROUND: The Global Allergy and Asthma European Network (GA2LEN) is a consortium of 26 leading European research centres committed to establish a European research area of excellence in the field of allergy and asthma. AIM: One of the GA2LEN work packages was designed to identify and compare the existing European birth cohort studies on asthma and atopic diseases. The present review compares their subjective and objective outcomes as well as exposure variables. METHODS: A common database was established to assess study characteristics of observational birth cohort studies designed to examine asthma and atopic diseases. Data were collected by visiting most of the participating research teams and interviewing all relevant study personnel. For each study, the type of objective/subjective outcome parameters and potentially influential factors were recorded precisely for every time point during follow-up. RESULTS: Eighteen birth cohort studies on asthma and atopic diseases were identified in eight European countries. Thirteen studies collected data on specific immunoglobulin E (IgE) to various inhalant and food allergens, whereas 12 performed skin prick tests (many at several time points during follow up). Several studies measured lung function, but across the cohorts no comparable standard procedures were used. For subjective evaluation of asthma and allergic rhinitis most studies applied the ISAAC questionnaire (sometimes modified), whereas the assessment of eczema was rather heterogeneous across the studies. CONCLUSION: This GA2LEN initiative established a unique common database of 18 European birth cohorts on asthma and atopic diseases. For selected cohorts, it seems that pooling data and performing common analyses may be possible to examine associations between certain exposure variables (e.g. pet ownership, tobacco smoke exposure and day-care) and selected outcome measures for atopy, asthma or allergic rhinitis (e.g. sensitization assessed by IgE or skin prick tests, doctor's diagnosis of asthma, parental perception regarding asthma/wheezing or hay fever symptoms).
Authors: Lars Lind; Sölve Elmståhl; Ebba Bergman; Martin Englund; Eva Lindberg; Karl Michaelsson; Peter M Nilsson; Johan Sundström Journal: Eur J Epidemiol Date: 2013-02-24 Impact factor: 8.082
Authors: N E Berentzen; V L van Stokkom; U Gehring; G H Koppelman; L A Schaap; H A Smit; A H Wijga Journal: Eur J Clin Nutr Date: 2014-08-13 Impact factor: 4.016
Authors: Stefan Wöhrl; Katja Radon; Johannes Ring; Katharina Moritz; Cezmi Akdis; Peter Burney; Paul Van Cauwenberge; Jean Bousquet; Torsten Zuberbier Journal: Wien Klin Wochenschr Date: 2009 Impact factor: 1.704
Authors: Jean Bousquet; James E Gern; Fernando D Martinez; Josep M Anto; Christine C Johnson; Patrick G Holt; Robert F Lemanske; Peter N Le Souëf; Robert S Tepper; Erika R M von Mutius; S Hasan Arshad; Leonard B Bacharier; Allan Becker; Kathleen Belanger; Anna Bergström; David I Bernstein; Michael D Cabana; Kecia N Carroll; Mario Castro; Philip J Cooper; Matthew W Gillman; Diane R Gold; John Henderson; Joachim Heinrich; Soo-Jong Hong; Daniel J Jackson; Thomas Keil; Anita L Kozyrskyj; Karin C Lødrup Carlsen; Rachel L Miller; Isabelle Momas; Wayne J Morgan; Patricia Noel; Dennis R Ownby; Mariona Pinart; Patrick H Ryan; Julie M Schwaninger; Malcolm R Sears; Angela Simpson; Henriette A Smit; Debra A Stern; Padmaja Subbarao; Rudolf Valenta; Xiaobin Wang; Scott T Weiss; Robert Wood; Anne L Wright; Rosalind J Wright; Alkis Togias; Peter J Gergen Journal: J Allergy Clin Immunol Date: 2014-03-15 Impact factor: 10.793
Authors: Tracey J Woodruff; Jennifer D Parker; Kate Adams; Michelle L Bell; Ulrike Gehring; Svetlana Glinianaia; Eun-Hee Ha; Bin Jalaludin; Rémy Slama Journal: Int J Environ Res Public Health Date: 2010-06-17 Impact factor: 3.390
Authors: Sabine Heinrich; Astrid Peters; Jessica Kellberger; Diana Ellenberg; Jon Genuneit; Dennis Nowak; Christian Vogelberg; Erika von Mutius; Gudrun Weinmayr; Katja Radon Journal: BMC Public Health Date: 2011-05-11 Impact factor: 3.295
Authors: Martine Vrijheid; Maribel Casas; Anna Bergström; Amanda Carmichael; Sylvaine Cordier; Merete Eggesbø; Esben Eller; Maria P Fantini; Mariana F Fernández; Ana Fernández-Somoano; Ulrike Gehring; Regina Grazuleviciene; Cynthia Hohmann; Anne M Karvonen; Thomas Keil; Manolis Kogevinas; Gudrun Koppen; Ursula Krämer; Claudia E Kuehni; Per Magnus; Renata Majewska; Anne-Marie Nybo Andersen; Evridiki Patelarou; Maria Skaalum Petersen; Frank H Pierik; Kinga Polanska; Daniela Porta; Lorenzo Richiardi; Ana Cristina Santos; Rémy Slama; Radim J Sram; Carel Thijs; Christina Tischer; Gunnar Toft; Tomáš Trnovec; Stephanie Vandentorren; Tanja G M Vrijkotte; Michael Wilhelm; John Wright; Mark Nieuwenhuijsen Journal: Environ Health Perspect Date: 2011-08-29 Impact factor: 9.031
Authors: Karin C Lødrup Carlsen; Stephanie Roll; Kai-Håkon Carlsen; Petter Mowinckel; Alet H Wijga; Bert Brunekreef; Maties Torrent; Graham Roberts; S Hasan Arshad; Inger Kull; Ursula Krämer; Andrea von Berg; Esben Eller; Arne Høst; Claudia Kuehni; Ben Spycher; Jordi Sunyer; Chih-Mei Chen; Andreas Reich; Anna Asarnoj; Carmen Puig; Olf Herbarth; Jestinah M Mahachie John; Kristel Van Steen; Stefan N Willich; Ulrich Wahn; Susanne Lau; Thomas Keil Journal: PLoS One Date: 2012-08-29 Impact factor: 3.240